Şunu aradınız:: cinkbacitracina (Slovence - İngilizce)

ker je treba ohraniti učinkovitost cinkbacitracina v humani medicini;
whereas the effectiveness of bacitracin zinc in human medicine should therefore be preserved;

ker selekcionirana odpornost iz uporabe cinkbacitracina kot dodatka hrani za živali neizogibno povečuje zalogo odpornosti proti cinkbacitracinu;
whereas selected resistances from the use of bacitracin zinc as a feed additive inevitably increase the reservoir of resistances to bacitracin zinc;

ker je za zaščito zdravja ljudi treba preklicati odobritev antibiotikov cinkbacitracina, spiramicina, virginiamicina in tilozinfosfata;
whereas, for the sake of protecting human health, the authorisations for the antibiotics bacitracin zinc, spiramycin, virginiamycin and tylosin phosphate should be withdrawn;

ker bi se ta odpornost lahko prenesla z živali na ljudi in znižala učinkovitost cinkbacitracina, ki se uporablja kot medicinski izdelek v humani medicini;
whereas these resistances could be transferred from animals to humans and reduce the effectiveness of bacitracin zinc used as a human medicinal product;

ker bi bilo prepoved uporabe antibiotikov cinkbacitracina, spiramicina, virginiamicina in tilozinfosfata treba šteti za začasen preventivni varnostni ukrep, ki bi ga lahko ponovno preučili glede na preiskave, ki se bodo izvajale, in uveljavljeni program nadzora;
whereas the prohibition on the use of the antibiotics bacitracin zinc, spiramycin, virginiamycin and tylosin phosphate ought to be perceived as an interim protective measure taken as a precaution, which could be reconsidered in the light of the investigations which will have been carried out and of the established surveillance programme;